Shackelford Pharma Inc. is a clinical stage biopharmaceutical company formed to develop medicines for neurological diseases with significant unmet patient needs. Founded by Dr . Alan Shackelford and leading medical industry executives, Shackelford Pharma is leveraging Dr. Shackelford’s real-world clinical experience to develop novel therapies for specific indications targeting the endocannabinoid system.